The Expanded Access Use of Viltolarsen in Duchenne Muscular Dystrophy With Confirmed Exon 53 Amenable Mutation
Clinical trial NCT04337112 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04337112
- Sponsor
- NS Pharma, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.